Ann Cohen Buys Shares of NAGE
Ann Cohen purchased 31,746 shares of NAGE on June 24, 2026.
Key Points
- Ann Cohen bought 31,746 shares of NAGE on June 24, 2026, with the stock trading at $3.42 on Saturday.
- Shares of NAGE have been observed by significant institutional investors, with BlackRock reducing its stake by 204,090 shares.
- Analysts from HC Wainwright & Co. and Canaccord Genuity maintained buy ratings with price targets of $11 and $10 respectively.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Ann Cohen made a notable purchase of 31,746 shares of NAGE on June 24, 2026. The stock was trading at $3.42 on Saturday. This insider activity is part of a broader trend of transactions involving NAGE shares.
Other Institutional Activity in NAGE
Several institutional investors have been active in NAGE shares recently. BlackRock, Inc. reduced its holdings by 204,090 shares, leaving it with 3,871,619 shares valued at approximately $17.07 million. Meanwhile, SteelPeak Wealth, LLC opened a new position with 3,373,000 shares worth about $14.87 million. Arrowstreet Capital, Limited Partnership increased its stake by 761,685 shares, resulting in a total of 2,378,437 shares valued at $10.49 million. Vanguard Capital Management LLC also initiated a new position with 2,149,277 shares valued at $9.48 million. Tieton Capital Management, LLC added 384,062 shares, bringing its total to 2,029,155 shares worth $8.95 million.
Niagen Bioscience, Inc. Stock Up 4.0%
On Saturday, shares of NAGE were trading at $3.42. The stock has attracted attention from investors and analysts alike.
$NAGE stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Niagen Bioscience, Inc.
On June 24, 2026, several insiders made purchases of NAGE shares. Ann Cohen, along with Jaksch Frank Jr, Ng Wang Yu Gary, Kristin Patrick, Steven Rubin, and Hamed Shahbazi, each bought 31,746 shares. These transactions were not part of any pre-planned trading plans.
Analysts Set New Price Targets
Analysts have been keeping a close eye on NAGE. On May 11, 2026, HC Wainwright & Co. maintained a buy rating with an $11 price target. Similarly, Canaccord Genuity maintained its buy rating with a $10 target on May 5, 2026.
Bottom Line
Ann Cohen's purchase of NAGE shares highlights ongoing interest in the company's stock. Institutional investors have been actively adjusting their positions, reflecting varied strategies. Analysts continue to show optimism with maintained buy ratings and substantial price targets. As always, it's important to remember that insider transactions are disclosed after the fact and may not indicate future performance.
Get Niagen Bioscience, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NAGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.